Your browser doesn't support javascript.
loading
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.
Kotecha, Dipak; Breithardt, Günter; Camm, A John; Lip, Gregory Y H; Schotten, Ulrich; Ahlsson, Anders; Arnar, David; Atar, Dan; Auricchio, Angelo; Bax, Jeroen; Benussi, Stefano; Blomstrom-Lundqvist, Carina; Borggrefe, Martin; Boriani, Giuseppe; Brandes, Axel; Calkins, Hugh; Casadei, Barbara; Castellá, Manuel; Chua, Winnie; Crijns, Harry; Dobrev, Dobromir; Fabritz, Larissa; Feuring, Martin; Freedman, Ben; Gerth, Andrea; Goette, Andreas; Guasch, Eduard; Haase, Doreen; Hatem, Stephane; Haeusler, Karl Georg; Heidbuchel, Hein; Hendriks, Jeroen; Hunter, Craig; Kääb, Stefan; Kespohl, Stefanie; Landmesser, Ulf; Lane, Deirdre A; Lewalter, Thorsten; Mont, Lluís; Nabauer, Michael; Nielsen, Jens C; Oeff, Michael; Oldgren, Jonas; Oto, Ali; Pison, Laurent; Potpara, Tatjana; Ravens, Ursula; Richard-Lordereau, Isabelle; Rienstra, Michiel; Savelieva, Irina.
Afiliação
  • Kotecha D; Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK.
  • Breithardt G; Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany.
  • Camm AJ; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Lip GYH; St George's University of London, London, UK.
  • Schotten U; Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK.
  • Ahlsson A; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Arnar D; School for Cardiovascular Diseases, Maastricht University, The Netherlands.
  • Atar D; Orebro University Hospital, Orebro, Sweden.
  • Auricchio A; The National University Hospital, Reykjavik, Iceland.
  • Bax J; Oslo University Hospital, Oslo, Norway.
  • Benussi S; Fondazione Cardiocentro Ticino, Lugano, Switzerland.
  • Blomstrom-Lundqvist C; Leiden University Medical Center, Leiden, The Netherlands.
  • Borggrefe M; University Hospital Zurich, Zurich, Switzerland.
  • Boriani G; Department of Cardiology, Institution of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Brandes A; University of Mannheim, Mannheim, Germany.
  • Calkins H; DIMES Department, University of Bologna, Bologna, Italy.
  • Casadei B; Odense University Hospital, Odense, Denmark.
  • Castellá M; The Johns Hopkins Hospital, Baltimore, MD, USA.
  • Chua W; Oxford University, Oxford, UK.
  • Crijns H; Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Dobrev D; Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK.
  • Fabritz L; University Hospital Maastricht, Maastricht, The Netherlands.
  • Feuring M; University Duisburg-Essen, Essen, Germany.
  • Freedman B; Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK.
  • Gerth A; University Hospital Münster, Münster, Germany.
  • Goette A; Boehringer Ingelheim Pharma GmbH & Co. KG, Germany.
  • Guasch E; University of Sydney, Sydney, Australia.
  • Haase D; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Hatem S; Ludwig-Maximilians-University, Munich, Germany.
  • Haeusler KG; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Heidbuchel H; St Vincenz Krankenhaus, Paderborn, Germany.
  • Hendriks J; Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Hunter C; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Kääb S; Pitié-Salpêtrière Hospital, Paris, France.
  • Kespohl S; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Landmesser U; Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Lane DA; Antwerp University Hospital, Antwerp, Belgium.
  • Lewalter T; University of Adelaide, Adelaide, Australia.
  • Mont L; Boehringer Ingelheim Pharma GmbH & Co. KG, Germany.
  • Nabauer M; Ludwig-Maximilians University Clinic, Munich, Germany & DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
  • Nielsen JC; Bayer HealthCare AG, Berlin, Germany.
  • Oeff M; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Oldgren J; HaeuslerCharité-Universitätsmedizin Berlin, Berlin, Germany.
  • Oto A; Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK.
  • Pison L; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Potpara T; Hospital-Munich Thalkirchen, Munich, Germany.
  • Ravens U; Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Richard-Lordereau I; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Rienstra M; Ludwig-Maximilians-University, Munich, Germany.
  • Savelieva I; Aarhus University Hospital, Aarhus, Denmark.
Europace ; 20(3): 395-407, 2018 03 01.
Article em En | MEDLINE | ID: mdl-29300976
ABSTRACT
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The population with AF is expected to expand considerably and yet, apart from anticoagulation, therapies used in AF have not been shown to consistently impact on mortality or reduce adverse cardiovascular events. New approaches to AF management, including the use of novel technologies and structured, integrated care, have the potential to enhance clinical phenotyping or result in better treatment selection and stratified therapy. Here, we report the outcomes of the 6th Consensus Conference of the Atrial Fibrillation Network (AFNET) and the European Heart Rhythm Association (EHRA), held at the European Society of Cardiology Heart House in Sophia Antipolis, France, 17-19 January 2017. Sixty-two global specialists in AF and 13 industry partners met to develop innovative solutions based on new approaches to screening and diagnosis, enhancing integration of AF care, developing clinical pathways for treating complex patients, improving stroke prevention strategies, and better patient selection for heart rate and rhythm control. Ultimately, these approaches can lead to better outcomes for patients with AF.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Cardiologia / Prestação Integrada de Cuidados de Saúde Tipo de estudo: Guideline / Prognostic_studies / Sysrev_observational_studies Limite: Humans Idioma: En Revista: Europace Assunto da revista: CARDIOLOGIA / FISIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Cardiologia / Prestação Integrada de Cuidados de Saúde Tipo de estudo: Guideline / Prognostic_studies / Sysrev_observational_studies Limite: Humans Idioma: En Revista: Europace Assunto da revista: CARDIOLOGIA / FISIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido